Variant position: 81 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 361 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human DKILDTALSKIG---EKSLFTKE LEHALEKNE----VDLVVHSLKDLP
Mouse DKILDTALSKIG---EKSLFTKE LENALEKNE----VDLVV
Rat DKILDTALSKIG---EKSLFTKE LENALEKNE----VDLVV
Bovine DKILDTALSKIG---EKSLFTKE LEHALERNE----VDLVV
Slime mold DKVLDVSLSKIG---DKGLFTKE LEDMMLNGT----IDLAV
Baker's yeast DQIQFKPLYSFG---GKALWTKE LEDHLYHDDPSKKLDLIV
Fission yeast DEILSKALFEFKRQLAKSLWTRE LEALLVTNQ----CRILV
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 361 Porphobilinogen deaminase
69 – 69 Phosphoserine
74 – 74 N6-acetyllysine
78 – 86
Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors.
Hessels J.; Voortman G.; van der Wagen A.; van der Elzen C.; Scheffer H.; Zuijderhoudt F.M.J.;
J. Inherit. Metab. Dis. 27:19-27(2004)
Cited for: VARIANT AIP PRO-81;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.